Home LiteratureArticle Details
PMID: 6354433 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S. Review

Drug resistance in Chinese hamster lung and mouse tumor cells.

Cancer treatment reports ·Vol. 67 ·No. 10 ·1983-10-00 ·Pages 859-67

Biedler JL, Chang TD, Meyers MB, Peterson RH, Spengler BA

Abstract

Studies of Chinese hamster and mouse cells with high levels of acquired resistance to dactinomycin, daunorubicin, or vincristine have shown that these different permeability mutants all display similar phenotypic alterations: dramatic changes toward normal cell morphology and growth behavior and substantially reduced oncogenic potential. All three resistant cell types show increased expression of a high molecular weight plasma membrane glycoprotein species, gp150. Uniquely, vincristine-resistant cells contain gene amplification-associated chromosome abnormalities (homogeneously staining regions or double minute chromosomes), and they oversynthesize a low molecular weight cytosolic protein (V19). Cells grown in the absence of drug are phenotypically unstable. Revertant cells decline in resistance, length or number of homogeneously staining regions or double minute chromosomes, and expression of gp150 and V19. These proteins are thus candidate products of amplified genes which may or may not be manifested cytogenetically. The phenomena of drug resistance and reverse transformation are currently being addressed in protein phosphorylation studies.

MeSH Terms
Animals Antineoplastic Agents/pharmacology Cell Line Chromosome Aberrations Cricetinae Cricetulus Daunorubicin/pharmacology Drug Resistance Gangliosides/analysis Gene Amplification Glycoproteins/analysis Lung/drug effects Mice Neoplasms, Experimental/drug therapy Phenotype Phosphorylation Proteins/analysis Tetrahydrofolate Dehydrogenase/genetics Vincristine/pharmacology
Chemicals
Antineoplastic Agents Gangliosides Glycoproteins Proteins Vincristine Tetrahydrofolate Dehydrogenase Daunorubicin
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Biedler J L
Chang T D
Meyers M B
Peterson R H
Spengler B A
Article Info
Journal
Cancer treatment reports
Abbr.
Cancer Treat Rep
ISSN
0361-5960
Published
1983-10-00
Pages
859-67
Language
English
Region
United States
NLM ID
7607107
Subset
IM
Grants
NCI NIH HHS · CA-08748 · United States
NCI NIH HHS · CA-28595 · United States
External Links
PubMed source
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]